サマリー

鉄過剰症の治療に使用される鉄キレート剤
市場の分析と洞察。鉄過剰症治療薬の世界市場
COVID-19の大流行により、世界の鉄過剰症治療薬の市場規模は2022年に百万米ドル相当と推定され、2022年から2028年の予測期間中にCAGR %で2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年に鉄過剰症治療薬の世界市場の%を占めたDeferasiroxは、2028年までに百万米ドルの価値を持ち、2022年から2028年まで修正された%のCAGRで成長すると予測されます。一方、病院セグメントは、この予測期間を通して％CAGRに変更されています。

中国の鉄過剰症治療薬の市場規模は2021年に百万米ドル、米国と欧州の鉄過剰症治療薬はそれぞれ百万米ドル、百万米ドルと評価されています。米国の割合は2021年に％、中国と欧州はそれぞれ％と％で、中国の割合は2028年に％に達すると予測され、分析期間2022-2028年を通じてCAGR％で、追跡しています。日本、韓国、東南アジアはアジアの注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％である。ヨーロッパの鉄過剰症治療薬の展望については、ドイツは2028年までに百万米ドルに達し、予測期間2022-2028年を通じてCAGR %を推移すると予測されています。
鉄過剰症治療薬の世界的な主要メーカーは、Novartis、Chiesi Group、Sun Pharma、Cipla、Natco Pharma、Taro Pharmなどです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。

鉄過剰症の治療薬の世界的な範囲とセグメント
鉄過剰症治療薬市場は、タイプ別および用途別に分類されます。世界の鉄過剰症治療薬市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
デフェラシロックス
デフェロキサミン
デフェリプロン
用途別セグメント
病院
小売店
その他

会社別
ノバルティス
Chiesiグループ
サンファーマ
シプラ社
ナトコファーマ
タロファーマ

地域別
北アメリカ
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
コロンビア
中東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 Iron Overload Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Iron Overload Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Deferasirox
1.2.3 Deferoxamine
1.2.4 Deferiprone
1.3 Market by Application
1.3.1 Global Iron Overload Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Iron Overload Therapeutics Sales Estimates and Forecasts 2017-2028
2.2 Global Iron Overload Therapeutics Revenue Estimates and Forecasts 2017-2028
2.3 Global Iron Overload Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Iron Overload Therapeutics Sales by Region
2.4.1 Global Iron Overload Therapeutics Sales by Region (2017-2022)
2.4.2 Global Sales Iron Overload Therapeutics by Region (2023-2028)
2.5 Global Iron Overload Therapeutics Revenue by Region
2.5.1 Global Iron Overload Therapeutics Revenue by Region (2017-2022)
2.5.2 Global Iron Overload Therapeutics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Iron Overload Therapeutics Sales by Manufacturers
3.1.1 Global Top Iron Overload Therapeutics Manufacturers by Sales (2017-2022)
3.1.2 Global Iron Overload Therapeutics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Iron Overload Therapeutics in 2021
3.2 Global Iron Overload Therapeutics Revenue by Manufacturers
3.2.1 Global Iron Overload Therapeutics Revenue by Manufacturers (2017-2022)
3.2.2 Global Iron Overload Therapeutics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Iron Overload Therapeutics Revenue in 2021
3.3 Global Iron Overload Therapeutics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Iron Overload Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Iron Overload Therapeutics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Iron Overload Therapeutics Sales by Type
4.1.1 Global Iron Overload Therapeutics Historical Sales by Type (2017-2022)
4.1.2 Global Iron Overload Therapeutics Forecasted Sales by Type (2023-2028)
4.1.3 Global Iron Overload Therapeutics Sales Market Share by Type (2017-2028)
4.2 Global Iron Overload Therapeutics Revenue by Type
4.2.1 Global Iron Overload Therapeutics Historical Revenue by Type (2017-2022)
4.2.2 Global Iron Overload Therapeutics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Iron Overload Therapeutics Revenue Market Share by Type (2017-2028)
4.3 Global Iron Overload Therapeutics Price by Type
4.3.1 Global Iron Overload Therapeutics Price by Type (2017-2022)
4.3.2 Global Iron Overload Therapeutics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Iron Overload Therapeutics Sales by Application
5.1.1 Global Iron Overload Therapeutics Historical Sales by Application (2017-2022)
5.1.2 Global Iron Overload Therapeutics Forecasted Sales by Application (2023-2028)
5.1.3 Global Iron Overload Therapeutics Sales Market Share by Application (2017-2028)
5.2 Global Iron Overload Therapeutics Revenue by Application
5.2.1 Global Iron Overload Therapeutics Historical Revenue by Application (2017-2022)
5.2.2 Global Iron Overload Therapeutics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Iron Overload Therapeutics Revenue Market Share by Application (2017-2028)
5.3 Global Iron Overload Therapeutics Price by Application
5.3.1 Global Iron Overload Therapeutics Price by Application (2017-2022)
5.3.2 Global Iron Overload Therapeutics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Iron Overload Therapeutics Market Size by Type
6.1.1 North America Iron Overload Therapeutics Sales by Type (2017-2028)
6.1.2 North America Iron Overload Therapeutics Revenue by Type (2017-2028)
6.2 North America Iron Overload Therapeutics Market Size by Application
6.2.1 North America Iron Overload Therapeutics Sales by Application (2017-2028)
6.2.2 North America Iron Overload Therapeutics Revenue by Application (2017-2028)
6.3 North America Iron Overload Therapeutics Market Size by Country
6.3.1 North America Iron Overload Therapeutics Sales by Country (2017-2028)
6.3.2 North America Iron Overload Therapeutics Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Iron Overload Therapeutics Market Size by Type
7.1.1 Europe Iron Overload Therapeutics Sales by Type (2017-2028)
7.1.2 Europe Iron Overload Therapeutics Revenue by Type (2017-2028)
7.2 Europe Iron Overload Therapeutics Market Size by Application
7.2.1 Europe Iron Overload Therapeutics Sales by Application (2017-2028)
7.2.2 Europe Iron Overload Therapeutics Revenue by Application (2017-2028)
7.3 Europe Iron Overload Therapeutics Market Size by Country
7.3.1 Europe Iron Overload Therapeutics Sales by Country (2017-2028)
7.3.2 Europe Iron Overload Therapeutics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Iron Overload Therapeutics Market Size by Type
8.1.1 Asia Pacific Iron Overload Therapeutics Sales by Type (2017-2028)
8.1.2 Asia Pacific Iron Overload Therapeutics Revenue by Type (2017-2028)
8.2 Asia Pacific Iron Overload Therapeutics Market Size by Application
8.2.1 Asia Pacific Iron Overload Therapeutics Sales by Application (2017-2028)
8.2.2 Asia Pacific Iron Overload Therapeutics Revenue by Application (2017-2028)
8.3 Asia Pacific Iron Overload Therapeutics Market Size by Region
8.3.1 Asia Pacific Iron Overload Therapeutics Sales by Region (2017-2028)
8.3.2 Asia Pacific Iron Overload Therapeutics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Iron Overload Therapeutics Market Size by Type
9.1.1 Latin America Iron Overload Therapeutics Sales by Type (2017-2028)
9.1.2 Latin America Iron Overload Therapeutics Revenue by Type (2017-2028)
9.2 Latin America Iron Overload Therapeutics Market Size by Application
9.2.1 Latin America Iron Overload Therapeutics Sales by Application (2017-2028)
9.2.2 Latin America Iron Overload Therapeutics Revenue by Application (2017-2028)
9.3 Latin America Iron Overload Therapeutics Market Size by Country
9.3.1 Latin America Iron Overload Therapeutics Sales by Country (2017-2028)
9.3.2 Latin America Iron Overload Therapeutics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Iron Overload Therapeutics Market Size by Type
10.1.1 Middle East and Africa Iron Overload Therapeutics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Iron Overload Therapeutics Revenue by Type (2017-2028)
10.2 Middle East and Africa Iron Overload Therapeutics Market Size by Application
10.2.1 Middle East and Africa Iron Overload Therapeutics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Iron Overload Therapeutics Revenue by Application (2017-2028)
10.3 Middle East and Africa Iron Overload Therapeutics Market Size by Country
10.3.1 Middle East and Africa Iron Overload Therapeutics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Iron Overload Therapeutics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Iron Overload Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Iron Overload Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Chiesi Group
11.2.1 Chiesi Group Corporation Information
11.2.2 Chiesi Group Overview
11.2.3 Chiesi Group Iron Overload Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Chiesi Group Iron Overload Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Chiesi Group Recent Developments
11.3 Sun Pharma
11.3.1 Sun Pharma Corporation Information
11.3.2 Sun Pharma Overview
11.3.3 Sun Pharma Iron Overload Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sun Pharma Iron Overload Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sun Pharma Recent Developments
11.4 Cipla
11.4.1 Cipla Corporation Information
11.4.2 Cipla Overview
11.4.3 Cipla Iron Overload Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cipla Iron Overload Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cipla Recent Developments
11.5 Natco Pharma
11.5.1 Natco Pharma Corporation Information
11.5.2 Natco Pharma Overview
11.5.3 Natco Pharma Iron Overload Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Natco Pharma Iron Overload Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Natco Pharma Recent Developments
11.6 Taro Pharm
11.6.1 Taro Pharm Corporation Information
11.6.2 Taro Pharm Overview
11.6.3 Taro Pharm Iron Overload Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Taro Pharm Iron Overload Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Taro Pharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Iron Overload Therapeutics Industry Chain Analysis
12.2 Iron Overload Therapeutics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Iron Overload Therapeutics Production Mode & Process
12.4 Iron Overload Therapeutics Sales and Marketing
12.4.1 Iron Overload Therapeutics Sales Channels
12.4.2 Iron Overload Therapeutics Distributors
12.5 Iron Overload Therapeutics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Iron Overload Therapeutics Industry Trends
13.2 Iron Overload Therapeutics Market Drivers
13.3 Iron Overload Therapeutics Market Challenges
13.4 Iron Overload Therapeutics Market Restraints
14 Key Findings in The Global Iron Overload Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer